Induction of a Strong HIV-Specific CD8+T Cell Response in Mice Using a Fowlpox Virus Vector Expressing an HIV-1 Multi-CTL-Epitope Polypeptide
- 1 June 2002
- journal article
- Published by Mary Ann Liebert Inc in Viral Immunology
- Vol. 15 (2) , 337-356
- https://doi.org/10.1089/08828240260066260
Abstract
Recombinant avipoxvirus vectors are attractive candidates for use in vaccination strategies for infections such as human immunodeficiency virus type 1 (HIV-1), where induction of a CD8+ T cell response is thought to be an important component of protective immunity. Here, we report the expression of a multiepitope polypeptide (TAB9) composed of the central 15 amino acids of the V3 loop from six different isolates of HIV-1 in a fowlpox virus (FWPV) vector, and the use of this vector (FPTAB9LZ) to induce strong HIV-specific CD8+ T cell responses in mice. In animals immunized twice intravenously with FPTAB9LZ, almost 2% of the CD8+ T cells in the spleen were shown to produce IFN-gamma in response to stimulation with HIV-1 peptides 1 week after the second immunization. The most dominant response was to the HIV-1 IIIB peptide. A strong HIV-specific response was also induced by intraperitoneal immunization of mice with FPTAB9LZ, whilst subcutaneous immunization elicited a weaker response. Intraperitoneal immunization with FPTAB9LZ was also shown to provide protection against challenge with a recombinant vaccinia virus expressing antigens, including those in TAB9. These results confirm the potential of FWPV vectors for use in HIV vaccination strategiesKeywords
This publication has 87 references indexed in Scilit:
- A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteersVaccine, 2001
- Cellular and Humoral Immune Responses to a Canarypox Vaccine Containing Human Immunodeficiency Virus Type 1 Env, Gag, and Pro in Combination with RGP120The Journal of Infectious Diseases, 2001
- A Canarypox Vector Expressing Cytomegalovirus (CMV) Glycoprotein B Primes for Antibody Responses to a Live Attenuated CMV Vaccine (Towne)The Journal of Infectious Diseases, 1999
- A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8+Cytotoxic T Lymphocyte Responses in Seronegative VolunteersThe Journal of Infectious Diseases, 1999
- Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNAScience, 1998
- Cytotoxic T Cell and Neutralizing Antibody Responses to Human Immunodeficiency Virus Type 1 Envelope with a Combination Vaccine RegimenThe Journal of Infectious Diseases, 1998
- Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector systemVaccine, 1996
- Protection against turkey rhinotracheitis pneumovirus (TRTV) induced by a fowlpox virus recombinant expressing the TRTV fusion glycoprotein (F)Vaccine, 1994
- An endogenously synthesized decamer peptide efficiently primes cytotoxic T cells specific for the HIV‐1 envelope glycoproteinEuropean Journal of Immunology, 1993
- Structure of vaccinia virus early promotersJournal of Molecular Biology, 1989